Only After The Dust Settles Tomorrow...

. . .will we discuss whether any political move on US pharmaceuticals pricing / access will actually take hold. Everything from November 2016 to tonight. . . has been mere bluster. Meaningless. Especially from Seema Verma and (of course) 45, but even FDA's Gottlieb. Now we will know what Congress will actually do. And make no mistake -- it will take an Act of Congress. It cannot be done by rule, or executive order.

Unless 45 wants to officially declare that his whole "beautiful" US economy is NOW in shambles, and tanking (i.e., never gonna' happen), he simply has no authority to set prices in pharma -- or any other indstry, for that matter. The only (Nixon era 1969) Act of Congress that would allow it. . . requires an express finding by the President, of an economic calamity -- system wide.

No need to waste electrons on. . . nonsense. So, come Thursday -- we will see. . . what's actually what.

[Side Note: This one, we've covered since early April 2018 -- an antitrust / access pricing would-be class action suit, in the Eastern District of Pennsylvania -- related to the combo MMR vaccines sold by Kenilworth, is likely headed to an entirely private arbitration. Now you know. Onward.] नमस्ते